OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 1,000 CYTK derivative securities | OQRO

Home
Insider trades
Cytokinetics
Officer exercised or converted 1,000 CYTK derivative securities

Insider trades

Insider trade

Officer exercised or converted 1,000 CYTK derivative securities

Traded Apr 7, 2026 · Filed Apr 8, 2026

CYTCytokineticsCYTK

1,000
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 7, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 8, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001061983-26-000034

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Apr 8, 2026, 8:18 PM UTC

Added to OQRO

Oct 6, 2026, 7:14 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

CYTOKINETICS INC

Issuer CIK

1061983

Ticker

CYTK

Reporting person

Fady Ibraham Malik

Relationship

Officer

Officer title

EVP Research & Development

Security

Non-Qualified Stock Option (Right to Buy)

Table

Derivative (Table II)

Transaction date

Apr 7, 2026

Transaction code

Shares / units

1,000

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

Ownership form

Direct

Amendment

Around the same time

Fady Ibraham MalikEVP Research & Development

Filed 5mo ago

3,500Shares · @ $7.80

Traded May 5 · filed the same day

Derivative exercise or conversion — not an open-market buy.

More Official record

Fady Ibraham Malik (EVP Research & Development) sold ~$271K of Cytokinetics

Automatic saleFiled 5mo ago

Fady Ibraham MalikEVP Research & Development

Filed 5mo ago

3,500Derivative units

Traded May 5 · filed the same day

Derivative exercise or conversion — not an open-market buy.

More Official record